Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
HCC1395
TNBC
Basal B
FTase Inhibitor I
Ftase
MAPK
12084.154
uM
inf
inf
0.7715 0.7715 0.0000 0.1395
-0.0309
1.2963
HCC1569
HER2amp
Basal A
Cetuximab
EGFR
ErbB
7447.102
uM
inf
inf
0.9613 0.9613 0.0000 0.0386
0.0310
1.6467
BT-20
TNBC
Basal A
Methotrexate
DHFR
Metabolism
5902.084
uM
inf
inf
0.9945 0.9945 0.0000 -0.0077
-0.0317
1.3532
Hs 578T
TNBC
Basal B
PD 98059
MEK
MAPK
10694.152
uM
inf
inf
0.8155 0.8155 0.0000 0.0947
0.0324
2.4238
SUM190PT
HER2amp
Luminal
Ribavirin
15358.211
uM
inf
inf
1.0036 1.0036 0.0000 -0.0073
-0.0327
1.3504
MDA-MB-468
TNBC
Basal A
Trametinib
MEK
MAPK
7906.012
uM
inf
inf
0.2629 0.2629 0.0000 0.1652
-0.0328
0.4916
MB 157
Unknown
Unknown
AG1024
IGF1R
RTK
7482.066
uM
inf
inf
1.0500 1.0500 0.0000 0.0332
-0.0335
1.1347
600MPE
HR+
Luminal
GM6001
MMP
MMP
5898.096
uM
inf
inf
0.8794 0.8794 0.0000 0.0460
-0.0341
0.6718
ZR-75-1
HR+
Luminal
FTase Inhibitor I
Ftase
MAPK
12003.167
uM
inf
inf
0.7304 0.7304 0.0000 0.2250
-0.0343
1.1158
HCC1419
HER2amp
Luminal
Sorafenib
PDGFR/VEGFR/KIT/FLT3
RTK
7437.084
uM
inf
inf
0.9273 0.9273 0.0000 0.1333
0.0343
0.4343
MCF7
HR+
Luminal
Cetuximab
EGFR
ErbB
9583.026
uM
inf
inf
0.9966 0.9966 0.0000 0.0156
-0.0344
1.2731
MDA-MB-453
TNBC
Luminal
Sorafenib
PDGFR/VEGFR/KIT/FLT3
RTK
7517.084
uM
inf
inf
0.8484 0.8484 0.0000 0.1100
-0.0346
1.4076
BT-474
HER2amp
Luminal
Glycyl-H-1152
ROCK2
12178.16
uM
inf
inf
0.7508 0.7508 0.0000 0.1609
0.0357
0.7392
HCC1428
HR+
Luminal
PD184352
MEK
MAPK
11936.155
uM
inf
inf
0.9166 0.9166 0.0000 0.0264
-0.0360
0.7332
HCC1428
HR+
Luminal
PD184352
MEK
MAPK
11936.155
uM
inf
inf
0.9166 0.9166 0.0000 0.0264
-0.0360
0.7332
Hs 578T
TNBC
Basal B
FTase Inhibitor I
Ftase
MAPK
10694.154
uM
inf
inf
0.9764 0.9764 0.0000 -0.0084
-0.0364
2.3045
MDA-MB-175-VII
HR+
Luminal
ICRF-193
TOP2
TOP
10642.139
uM
inf
inf
0.8934 0.8934 0.0000 0.0557
-0.0365
0.7017
BT-474
HER2amp
Luminal
Selumetinib
MEK
MAPK
12291.155
uM
inf
inf
0.8945 0.8945 0.0000 -0.0163
0.0368
0.4532
MDA-MB-134-VI
HR+
Luminal
FR180204
ERK1/2
MAPK
10519.137
uM
inf
inf
0.8748 0.8748 0.0000 0.0872
-0.0369
1.0772
MDA-MB-361
HER2amp
Luminal
Cetuximab
EGFR
ErbB
7895.018
uM
inf
inf
0.9756 0.9756 0.0000 0.0240
-0.0375
1.2916
HCC1428
HR+
Luminal
ICRF-193
TOP2
TOP
11936.157
uM
inf
inf
0.7052 0.7052 0.0000 0.1856
-0.0376
0.9133
MDA-MB-361
HER2amp
Luminal
ICRF-193
TOP2
TOP
10999.151
uM
inf
inf
0.6771 0.6771 0.0000 0.0774
0.0387
0.7090
MDA-MB-361
HER2amp
Luminal
AG1024
IGF1R
RTK
7506.066
uM
inf
inf
0.9368 0.9368 0.0000 0.0689
0.0388
1.1486
HCC2185
TNBC
Luminal
PD184352
MEK
MAPK
12192.155
uM
inf
inf
0.7159 0.7159 0.0000 0.2130
0.0390
0.7451
HCC2185
TNBC
Luminal
PD184352
MEK
MAPK
12192.155
uM
inf
inf
0.7159 0.7159 0.0000 0.2130
0.0390
0.7451